Form D · Other Technology

Auxergen, Inc.

Balitmore, MD · CIK 0001853250

Offering snapshot reported May 5, 2023 · SEC filing

Reported sold
$535K
Offering amount: $1M
Investors reported
11
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Apr 5, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$268K$535KApr 16, 2021: $125,000.00Apr 16, 2021Aug 24, 2022: $455,000.00Aug 24, 2022May 5, 2023: $535,000.00May 5, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$455,000 → $535,000
  • Reported investors7 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2023Amendment$535,000$80,000vs Aug 24, 202211SEC filing
Aug 24, 2022Amendment$455,000$330,000vs Apr 16, 20217SEC filing
Apr 16, 2021Initial$125,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-396191

Source: Form D, filed May 5, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory Contreras Director, Executive
Ting Yu Yeh Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
701 East Pratt Street
Balitmore, MD, 21202